Get started
Author

Ceren Mordağ Çiçek

Observed names: Ceren MORDAĞ ÇİÇEK, Ceren Mordag, Ceren Mordag Cicek, Ceren Mordağ çiçek
ORCID: 0000-0002-9140-1453
Observed ORCID: 0000-0002-9140-1453
OpenAlex ID: A5092956786
Prognostic Factors in High Grade Osteosarcoma Patients Who Received Neoadjuvant Therapy and Subsequently Underwent Surgery: Data from the Turkish Oncology Group
2025 · Nadiye Sever, Fatih Şimşek, et al. · Journal of Clinical Medicine · 19
A comparative analysis of large language models for providing oral cavity cancer information
2026 · Eda İzgi, Turan Canmurat İzgi, et al. · Scientific Reports · 2
PDF
Outcomes of First-Line PARP Inhibitor Therapy in Ovarian Cancer: A Multicenter Retrospective Analysis
2026 · Baris Koksal, Hasan Cagri Yildirim, et al. · Journal of Clinical Medicine · 2
PDF
Real-world comparison of doxorubicin–ifosfamide versus gemcitabine–docetaxel regimens in metastatic uterine leiomyosarcoma: a multicenter retrospective study
2025 · Salih Tunbekici, Gokhan Sahin, et al. · Discover Oncology · 2
PDF
Quality analysis of YouTube videos in the management of hyperlipidemia in adults
2023 · Mercan TAŞTEMUR, Ceren MORDAĞ ÇİÇEK · Journal of Health Sciences and Medicine · 2
PDF
Efficacy and safety of doxorubicin–ifosfamide versus gemcitabine–docetaxel as first‐line therapy in advanced nonuterine leiomyosarcoma: A multicenter real‐world study
2025 · Salih Tunbekici, Gokhan Sahin, et al. · International Journal of Cancer · 1
Efficacy of Second-Line Treatments After Atezolizumab and Bevacizumab in Advanced Hepatocellular Carcinoma and Related Prognostic Factors: A Multicenter Study by the Turkish Oncology Group (TOG)
2025 · Nargiz Majidova, Sendag Yaslıkaya, et al. · The Turkish Journal of Gastroenterology · 1
PDF
Prevalence and Prognostic Significance of Positron Emission Tomography–Computed Tomography–Defined Low Skeletal Muscle Mass (Radiological Sarcopenia) in Metastatic Breast Cancer
2026 · Taliha Güçlü Kantar, Semra Taş, et al. · Cerrahpasa Medical Journal
PDF
Prognostic Role of Inflammatory Indices and Real-World Outcomes in HER2-Positive Metastatic Breast Cancer Treated with Trastuzumab Emtansine
2026 · Taliha Güçlü Kantar, Tolga Doğan, et al. · Diagnostics
Role of Prognostic Nutritional Index and C-Reactive Protein/Albumin Ratio in Prognosis of Locally Advanced Nasopharyngeal Carcinoma
2026 · Taliha Güçlü Kantar, Tolga Doğan, et al. · Medicina
PDF
Meme Kanseri
2026 · Semra Taş, Ali Alper Solmaz, et al. · Akademisyen Kitabevi eBooks
PDF
Meme Kanseri Tedavisinde Kullanılan Kemoterapotiklerin Toksisite Yönetimi
2026 · Ceren Mordağ Çiçek · Akademisyen Kitabevi eBooks
Prognostic Impact of Cetuximab-Related Hypomagnesemia and Hypokalemia in RAS/RAF Wild-Type Colorectal Cancer: A Multicenter Study
2026 · Halil Göksel Güzel, Derya Kıvrak Salim, et al. · Cancer Management and Research
PDF
Prognostic impact of hand-foot skin reaction in regorafenib-treated adult-type diffuse gliomas: A multicenter Turkish Oncology Group study
2025 · Safa Can Efil, Burak Bilgin, et al. · Scientific Reports
PDF
Prognostic Value of a New Marker, IBI Score and NLR Change in Non-Small Cell Lung Cancer Patients Receiving Immune Checkpoint Inhibitors (Prognostic value of IBI score and NLR change in NSCLC)
2025 · Melek Özdemir, Gamze Gokoz Dogu, et al. · Muğla Sıtkı Koçman Üniversitesi Tıp Dergisi
PDF
The impact of SARS-CoV-2 infection on the survival in NSCLC patients undergoing immunotherapy
2025 · Melek Özdemir, Gamze Gokoz Dogu, et al. · Pamukkale Medical Journal
PDF
Use of albumin and CRP related immuno-nutritional markers for prediction of locoregional response to treatment in unresectable hepatocellular carcinoma
2024 · Melek Özdemir, Gamze Gokoz Dogu, et al. · Pamukkale Medical Journal
Works count: 17
Citation count: 29
H-index: 2
I10-index: 1
Year
Topic
Type